丙氨酸氨基转移酶与γ-谷氨酰转移酶预测儿童非酒精性脂肪性肝炎组织学改善
基于CyNCh临床试验146名儿童数据,评估肝化学指标与肝组织学改善的关系。组织学改善(NAFLD活动评分下降≥2分且纤维化无恶化)见于43例(30%)。基线及52周GGT变化预测组织学改善(AUROC 0.79),ALT变化预测临界区1 NASH和纤维化改善(AUROC均0.80),加入临床参数后性能提升,并在TONIC试验中验证。
要点
- 儿童NAFLD中,血清ALT和GGT的动态变化与肝组织学改善相关。
- 基线及52周GGT变化可预测组织学改善,AUROC为0.79。
- 基线及52周ALT变化可预测临界区1 NASH和纤维化改善,AUROC均为0.80。
核心结论
- 在NAFLD儿童中,血清ALT和GGT的动态变化与肝组织学变化相关,可能是组织学反应的有力指标。
研究设计与样本
- 研究纳入CyNCh临床试验的146名儿童,使用基线及52周ALT、AST、GGT数据构建多变量模型,并在TONIC试验中验证。
主要发现
- 组织学改善(NAFLD活动评分下降≥2分且纤维化无恶化)发生于43例(30%)。
- 基线有临界区1 NASH的46例中,28%(12/46)发生缓解。
- 组织学改善模型保留基线及GGT变化(P<0.0001,AUROC 0.79,95%CI 0.71-0.87)。
- 临界区1 NASH模型保留基线及ALT变化(P=0.0004,AUROC 0.80,95%CI 0.67-0.93)。
- 纤维化模型保留基线及ALT变化(P<0.001,AUROC 0.80,95%CI 0.67-0.93)。
关键数值与推荐
- 组织学改善定义为NAFLD活动评分下降≥2分且纤维化无恶化。
- 加入额外临床参数后,组织学改善AUROC提升至0.89(95%CI 0.82-0.95)。
- 加入额外临床参数后,临界区1 NASH AUROC提升至0.91(95%CI 0.83-0.99)。
- 加入额外临床参数后,纤维化AUROC提升至0.89(95%CI 0.82-0.94)。
临床怎么用
- 在儿童NAFLD监测中,可动态监测血清ALT和GGT变化以辅助预测肝组织学改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Predictive, noninvasive tools are needed to monitor key features of nonalcoholic fatty liver disease (NAFLD) in children that relate to improvement in liver histology. The purpose of this study was to evaluate the relationship between liver chemistries and liver histology using data from the CyNCh (Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children) clinical trial. APPROACH AND RESULTS: This study included 146 children. Improvement in liver histology, defined as decrease in nonalcoholic fatty liver disease (NAFLD) Activity Score ≥2 points without worsening of fibrosis, occurred in 43 participants (30%). There were 46 participants with borderline zone 1 nonalcoholic steatohepatitis (NASH) at baseline, with resolution in 28% (12 of 46). Multivariate models were constructed using baseline and change in alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) at 52 weeks, for improvement in (1) liver histology primary outcome, (2) borderline zone 1 NASH, and (3) fibrosis. For improvement in histology, the model (P < 0.0001) retained baseline and change in GGT (area under the receiver operating characteristic [AUROC], 0.79; 95% confidence interval [CI], 0.71-0.87). For borderline zone 1 NASH, the model (P = 0.0004) retained baseline and change in ALT (AUROC, 0.80; 95% CI, 0.67-0.93). For fibrosis, the model (P < 0.001) retained baseline and change in ALT (AUROC, 0.80; 95% CI, 0.67-0.93). Additional clinical parameters were added to the models using Akaike's information criterion selection, and significantly boosted performance: improvement in histology with AUROC of 0.89 (95% CI, 0.82-0.95), borderline zone 1 NASH with AUROC of 0.91 (95% CI, 0.83-0.99), and fibrosis with AUROC of 0.89 (95% CI, 0.82-0.94). Models were validated using data from the TONIC (Treatment of Nonalcoholic Fatty Liver Disease in Children) trial. CONCLUSIONS: In children with NAFLD, dynamic changes in serum ALT and GGT are associated with change in liver histology and appear to be powerful indicators of histological response.
引用
- Newton KP, Lavine JE, Wilson L, et al. Alanine Aminotransferase and Gamma-Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis. Hepatology. 2020. PMID: 32416645. doi:10.1002/hep.31317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。